Industry Briefs: October 15, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Paladin Labs has entered into a licensing agreement with QRxPharma whereby Paladin received the exclusive rights to market and sell Moxduo, for treating acute pain, in Canada.
Theravance and Merck & Co. have agreed to discover, develop, and commercialize small-molecule therapeutics directed toward a target being investigated for treating of hypertension and heart failure.
People News
Amgen has appointed Cynthia Patton as senior vice-president and chief compliance officer.
Sirona Biochem has named Neil Belenkie as CEO.
Unilife has expanded its commercial development team with the appointment of four senior executives.